MDMB-FUBINACA (aka MDMB(N)-Bz-F), chemical name Methyl (S)-2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, a designer drug or a new psychoactive substance (NPS), was identified in three commercially available e-liquids formulated for electronic cigarette use. The e-liquids were evaluated using direct analysis in real time ion source attached to a time of flight mass spectrometer (DART-MS) and gas chromatograph mass spectrometer (GC-MS) to identify active ingredients/drugs, flavorants, and other possible constituents. The e-liquids were also evaluated for alcohol content by headspace gas chromatography with flame ionization detector (HS-GC-FID). The aerosol produced from the e-liquids by use of an e-cigarette was analyzed by solid phase micro-extraction gas chromatography mass spectrometry (SPME-GC-MS) to ensure delivery of the active ingredient/drug. Propylene glycol, vegetable glycerin, MDMB-FUBINACA, alcohol content and a flavor profile were determined for each of the e-liquids. MDMB-FUBINACA was determined to be the major active ingredient in all three e-liquids and was successfully detected by SPME-GC-MS in the aerosol generated by a KangerTech Aerotank clearomizer/electronic cigarette.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511053 | PMC |
| http://dx.doi.org/10.1016/j.forsciint.2016.12.031 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Statistical analyses plan for "MAGnItude of cigarette substitutioN after initiation oF e-cigarettes and its ImpaCt on biomArkers of exposure and potenTial harm in dual users": MAGNIFICAT trial.
Heliyon
November 2024
Department of Clinical and Experimental Medicine (CLINMED), University of Catania, Italy.
Background: The substitution of combustible cigarettes (CC) with non-combustible nicotine alternatives, such as e-cigarettes (EC), significantly lowers exposure to harmful chemicals. However, many individuals who use ECs continue smoking CCs, becoming dual users and remaining at increased risk of toxin exposure. This study will examine how the reduction in cigarettes smoked per day (CPD) after switching to ECs correlates with changes in biomarkers of exposure (BoE) and potential harm (BoPH) to evaluate the extent of harm in dual users.
View Article and Find Full Text PDFMethods for a Non-Targeted Qualitative Analysis and Quantification of Benzene, Toluene, and Xylenes by Gas Chromatography-Mass Spectrometry of E-Liquids and Aerosols in Commercially Available Electronic Cigarettes in Mexico.
Int J Environ Res Public Health
September 2024
Health Secretary, Homero 213, Piso 15 Col. Chapultepec Morales, D.T. Miguel Hidalgo, Mexico City 11570, Mexico.
The chemical components of the e-liquids and aerosols contained in electronic nicotine delivery systems (ENDSs), better known as vapes, were evaluated. The analytical technique used was gas chromatography-mass spectrometry, where the extraction and injection methods were established in this study. The work consisted of the analysis of twenty samples of disposable electronic cigarettes prefilled with new e-liquid, of a known brand, flavor, volume, and, in some of them, the percentage of nicotine and the number of puffs per device were indicated on the label.
View Article and Find Full Text PDFCost Comparison and Spending on Tobacco Products: Evidence from A Nationally Representative Sample of Adult E-Cigarette Users.
Nicotine Tob Res
October 2024
Center for Tobacco Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States.
Introduction: Over 20 states and local jurisdictions in the U.S. have imposed e-cigarette taxes.
View Article and Find Full Text PDFFlavored electronic nicotine delivery system product use among adults in New York State post-statewide restriction implementation.
J Public Health Policy
December 2024
Roswell Park Comprehensive Cancer Center Department of Health Behavior, Buffalo, NY, USA.
In May 2020, New York State restricted the sale of flavored e-liquids, excluding tobacco flavor. We conducted a Web-based survey to assess support and changes in use behavior between July and October 2020 (n = 946), with a follow-up between April and June 2021 (n = 542). Most electronic nicotine delivery system (ENDS) users (n = 82/55) continued to use, with 39%/33% reporting continuing to purchase flavored e-liquids, 20%/32% reporting using tobacco flavor, 5%/6% reporting quitting ENDS and smoking cigarettes, and 8%/3% reporting quitting ENDS and not smoking cigarettes.
View Article and Find Full Text PDFHarmful and Potentially Harmful Constituents in E-Liquids and Aerosols from Electronic Nicotine Delivery Systems (ENDS).
Chem Res Toxicol
July 2024
Office of Science, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, Maryland 20993-0002, United States.
Article Synopsis
- In 2012, the FDA identified 93 harmful constituents in tobacco products and later regulated electronic nicotine delivery systems (ENDS) in 2016, but knowledge gaps remained about harmful constituents in ENDS.
- Researchers conducted literature searches and experiments to quantify harmful constituents in 37 ENDS brands, discovering 66 harmful constituents in e-liquids and 68 in aerosols, with significant quantifiable results.
- The quantifiable findings (39% in e-liquids and 37% in aerosols) suggest potential harmful constituent transfer, which can guide manufacturers and regulators in understanding health risks associated with ENDS.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!